Pfizer, BioNTech to Supply EU With Additional 100 Million Doses of Covid-19 Vaccine
By Chris Wack
Pfizer Inc. and BioNTech SE said Tuesday they will supply an
additional 100 million doses of Comirnaty, the companies' Covid-19
vaccine, to the 27 European Union member states in 2021.
The companies said this announcement is a result of the European
Commission's decision to exercise its option to buy an additional
100 million doses under its Advanced Purchase Agreement signed Nov.
This agreement brings the total number of doses to be delivered
to the EU to 300 million.
The additional 100 million doses will be delivered in 2021,
supporting the vaccination campaigns which started two days ago in
all 27 member states.
Comirnaty will be produced in BioNTech's and Pfizer's plants in
Europe. The distribution of Comirnaty by the EU member states will
continue to be determined according to the populations identified
in EU and national guidance.
The Pfizer-BioNTech Covid-19 vaccine hasn't been approved or
licensed by the U.S. Food and Drug Administration, but has been
authorized for emergency use by FDA under an Emergency Use
Authorization to prevent Covid-19 for use in individuals 16 years
of age and older.
Write to Chris Wack at firstname.lastname@example.org
(END) Dow Jones Newswires
December 29, 2020 13:39 ET (18:39 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.